Cytotoxic Effects of Hellebrigenin and Arenobufagin Against Human Breast Cancer Cells
Development of new therapeutic strategies for breast cancer is urgently needed due to the sustained emergence of drug resistance, tumor recurrence and metastasis. To gain a novel insight into therapeutic approaches to fight against breast cancer, the cytocidal effects of hellebrigenin (Helle) and ar...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-08-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.711220/full |
| _version_ | 1819136662535405568 |
|---|---|
| author | Yu Zhang Yu Zhang Bo Yuan Baolin Bian Haiyu Zhao Anna Kiyomi Hideki Hayashi Yui Iwatani Munetoshi Sugiura Norio Takagi |
| author_facet | Yu Zhang Yu Zhang Bo Yuan Baolin Bian Haiyu Zhao Anna Kiyomi Hideki Hayashi Yui Iwatani Munetoshi Sugiura Norio Takagi |
| author_sort | Yu Zhang |
| collection | DOAJ |
| description | Development of new therapeutic strategies for breast cancer is urgently needed due to the sustained emergence of drug resistance, tumor recurrence and metastasis. To gain a novel insight into therapeutic approaches to fight against breast cancer, the cytocidal effects of hellebrigenin (Helle) and arenobufagin (Areno) were investigated in human estrogen receptor (ER)-positive breast cancer cell line MCF-7 and triple-negative breast cancer cell line MDA-MB-231. Helle exhibited more potent cytotoxicity than Areno in both cancer cells, and MCF-7 cells were more susceptible to both drugs in comparison with MDA-MB-231 cells. Apoptotic-like morphological characteristics, along with the downregulation of the expression level of Bcl-2 and Bcl-xL and the upregulation of the expression level of Bad, were observed in Helle-treated MCF-7 cells. Helle also caused the activation of caspase-8, caspase-9, along with the cleavage of poly(ADP-ribose) polymerase in MCF-7 cells. Helle-mediated necrosis-like phenotype, as evidenced by the increased propidium iodide (PI)-positive cells was further observed. G2/M cell cycle arrest was also induced by Helle in the cells. Upregulation of the expression level of p21 and downregulation of the expression level of cyclin D1, cyclin E1, cdc25C and survivin were observed in MCF-7 cells treated with Helle and occurred in parallel with G2/M arrest. Autophagy was triggered in MCF-7 cells and the addition of wortmannin or 3-MA, two well-known autophagy inhibitors, slightly but significantly rescued the cells. Furthermore, similar alterations of some key molecules associated with the aforementioned biological phenomena were observed in MDA-MB-231 cells. Intriguingly, the numbers of PI-positive cells in Helle-treated MCF-7 cells were significantly reduced by wortmannin and 3-MA, respectively. In addition, Helle-triggered G2/M arrest was significantly corrected by wortmannin, suggesting autophagy induction contributed to Helle-induced cytotoxicity of breast cancer cells by modulating necrosis and cell cycle arrest. Collectively, our results suggested potential usefulness of both Helle and Areno in developing therapeutic strategies to treat patients with different types of breast cancer, especially ER-positive breast cancer. |
| first_indexed | 2024-12-22T10:38:33Z |
| format | Article |
| id | doaj.art-ec9677b039814fcd9403936456c38480 |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-12-22T10:38:33Z |
| publishDate | 2021-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-ec9677b039814fcd9403936456c384802022-12-21T18:29:07ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-08-011110.3389/fonc.2021.711220711220Cytotoxic Effects of Hellebrigenin and Arenobufagin Against Human Breast Cancer CellsYu Zhang0Yu Zhang1Bo Yuan2Baolin Bian3Haiyu Zhao4Anna Kiyomi5Hideki Hayashi6Yui Iwatani7Munetoshi Sugiura8Norio Takagi9Department of Applied Biochemistry, Tokyo University of Pharmacy & Life Sciences, Hachioji, JapanInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, ChinaLaboratory of Pharmacology, School of Pharmacy, Faculty of Pharmaceutical Sciences, Josai University, Sakado, JapanInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, ChinaInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, ChinaDepartment of Drug Safety and Risk Management, Tokyo University of Pharmacy & Life Sciences, Hachioji, JapanDepartment of Applied Biochemistry, Tokyo University of Pharmacy & Life Sciences, Hachioji, JapanDepartment of Applied Biochemistry, Tokyo University of Pharmacy & Life Sciences, Hachioji, JapanDepartment of Drug Safety and Risk Management, Tokyo University of Pharmacy & Life Sciences, Hachioji, JapanDepartment of Applied Biochemistry, Tokyo University of Pharmacy & Life Sciences, Hachioji, JapanDevelopment of new therapeutic strategies for breast cancer is urgently needed due to the sustained emergence of drug resistance, tumor recurrence and metastasis. To gain a novel insight into therapeutic approaches to fight against breast cancer, the cytocidal effects of hellebrigenin (Helle) and arenobufagin (Areno) were investigated in human estrogen receptor (ER)-positive breast cancer cell line MCF-7 and triple-negative breast cancer cell line MDA-MB-231. Helle exhibited more potent cytotoxicity than Areno in both cancer cells, and MCF-7 cells were more susceptible to both drugs in comparison with MDA-MB-231 cells. Apoptotic-like morphological characteristics, along with the downregulation of the expression level of Bcl-2 and Bcl-xL and the upregulation of the expression level of Bad, were observed in Helle-treated MCF-7 cells. Helle also caused the activation of caspase-8, caspase-9, along with the cleavage of poly(ADP-ribose) polymerase in MCF-7 cells. Helle-mediated necrosis-like phenotype, as evidenced by the increased propidium iodide (PI)-positive cells was further observed. G2/M cell cycle arrest was also induced by Helle in the cells. Upregulation of the expression level of p21 and downregulation of the expression level of cyclin D1, cyclin E1, cdc25C and survivin were observed in MCF-7 cells treated with Helle and occurred in parallel with G2/M arrest. Autophagy was triggered in MCF-7 cells and the addition of wortmannin or 3-MA, two well-known autophagy inhibitors, slightly but significantly rescued the cells. Furthermore, similar alterations of some key molecules associated with the aforementioned biological phenomena were observed in MDA-MB-231 cells. Intriguingly, the numbers of PI-positive cells in Helle-treated MCF-7 cells were significantly reduced by wortmannin and 3-MA, respectively. In addition, Helle-triggered G2/M arrest was significantly corrected by wortmannin, suggesting autophagy induction contributed to Helle-induced cytotoxicity of breast cancer cells by modulating necrosis and cell cycle arrest. Collectively, our results suggested potential usefulness of both Helle and Areno in developing therapeutic strategies to treat patients with different types of breast cancer, especially ER-positive breast cancer.https://www.frontiersin.org/articles/10.3389/fonc.2021.711220/fullbreast cancer cellshellebrigeninarenobufaginapoptosisnecrosisG2/M arrest |
| spellingShingle | Yu Zhang Yu Zhang Bo Yuan Baolin Bian Haiyu Zhao Anna Kiyomi Hideki Hayashi Yui Iwatani Munetoshi Sugiura Norio Takagi Cytotoxic Effects of Hellebrigenin and Arenobufagin Against Human Breast Cancer Cells Frontiers in Oncology breast cancer cells hellebrigenin arenobufagin apoptosis necrosis G2/M arrest |
| title | Cytotoxic Effects of Hellebrigenin and Arenobufagin Against Human Breast Cancer Cells |
| title_full | Cytotoxic Effects of Hellebrigenin and Arenobufagin Against Human Breast Cancer Cells |
| title_fullStr | Cytotoxic Effects of Hellebrigenin and Arenobufagin Against Human Breast Cancer Cells |
| title_full_unstemmed | Cytotoxic Effects of Hellebrigenin and Arenobufagin Against Human Breast Cancer Cells |
| title_short | Cytotoxic Effects of Hellebrigenin and Arenobufagin Against Human Breast Cancer Cells |
| title_sort | cytotoxic effects of hellebrigenin and arenobufagin against human breast cancer cells |
| topic | breast cancer cells hellebrigenin arenobufagin apoptosis necrosis G2/M arrest |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2021.711220/full |
| work_keys_str_mv | AT yuzhang cytotoxiceffectsofhellebrigeninandarenobufaginagainsthumanbreastcancercells AT yuzhang cytotoxiceffectsofhellebrigeninandarenobufaginagainsthumanbreastcancercells AT boyuan cytotoxiceffectsofhellebrigeninandarenobufaginagainsthumanbreastcancercells AT baolinbian cytotoxiceffectsofhellebrigeninandarenobufaginagainsthumanbreastcancercells AT haiyuzhao cytotoxiceffectsofhellebrigeninandarenobufaginagainsthumanbreastcancercells AT annakiyomi cytotoxiceffectsofhellebrigeninandarenobufaginagainsthumanbreastcancercells AT hidekihayashi cytotoxiceffectsofhellebrigeninandarenobufaginagainsthumanbreastcancercells AT yuiiwatani cytotoxiceffectsofhellebrigeninandarenobufaginagainsthumanbreastcancercells AT munetoshisugiura cytotoxiceffectsofhellebrigeninandarenobufaginagainsthumanbreastcancercells AT noriotakagi cytotoxiceffectsofhellebrigeninandarenobufaginagainsthumanbreastcancercells |